Helmholtz Institute Würzburg<p>The World Antimicrobial Resistance Awareness Week (<a href="https://helmholtz.social/tags/WAAW" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>WAAW</span></a>) starts tomorrow, but at the <a href="https://helmholtz.social/tags/HIRI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HIRI</span></a>, the battle against <a href="https://helmholtz.social/tags/AntibioticResistance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AntibioticResistance</span></a> is a year-round task. 🦠 We are searching for new targets in various germs, as conventional antibiotics are becoming increasingly ineffective: <a href="https://www.helmholtz-hiri.de/en/newsroom/features-stories/the-silent-pandemic/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">helmholtz-hiri.de/en/newsroom/</span><span class="invisible">features-stories/the-silent-pandemic/</span></a></p><p>One promising solution are programmable antibiotics, ASOs, studied by the laboratory of HIRI Director Jörg Vogel. They target <a href="https://helmholtz.social/tags/mRNAs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mRNAs</span></a> needed by bacteria to synthesize new proteins & replicate. 🧬</p>